跳至主要内容
临床试验/NCT01829087
NCT01829087Unknown不适用

Botulinum Toxin A to Treat Flexion Contracture After Total Knee Arthroplasty: A Double-Blinded Randomized Controlled Study

Rothman Institute Orthopaedics1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2012年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
140
试验地点
1
主要终点
Range of Motion: knee

研究概览

简要总结

The goal of this research project is to evaluate injections of botulinum toxin A (Botox) as the treatment for knee flexion contracture after total knee arthroplasty (TKA). The current treatment for patients who do not achieve full extension of the knee (flexion contracture) after TKA consists of an aggressive physical therapy program, home stretching program, and the use of an extension orthosis (brace). Many patients do not tolerate wearing these braces. This initial project is designed to use injections of Botox as an adjunct to the standard current treatment and evaluate its efficacy. It is our hypothesis that a single injection into the hamstrings in addition to routine postoperative rehabilitation will result in improved knee extension and this improvement in function should endure without further treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is at least 18 years of age
  • Subject had a total knee replacement or total knee replacement revision surgery performed at Main Line hospitals such as Bryn Mawr Hospital, Lankenau Hospital, and Riddle Hospital
  • Subject is measured to have at least 10 degree flexion contracture of the operative knee four to six weeks following surgery
  • Subject has the willingness to complete scheduled follow up evaluations as described in the informed consent

排除标准

  • Subject is currently involved in another study or has received investigational product or treatment within the last 30 days
  • Subject is a prisoner
  • Subject is anticipated to be non-compliant
  • Subject is known to be pregnant
  • Subject is mentally incompetent or unable to understand what participation in the study entails
  • The subject has a known sensitivity or allergic reaction to Botulinum Toxin A and albumin
  • The subject is unwilling or unable to give consent or to comply with the follow up program

研究组 & 干预措施

Botox injection

Experimental

干预措施: Botox (Drug)

Control

Placebo Comparator

干预措施: placebo (Drug)

结局指标

主要结局

Range of Motion: knee

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验